Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | GFER | P55789 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 4/20 | 0.46 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 2/20 | 0.39 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3156612 | 0.90 | MAOB (0.62) | MAPTALDH1A1CYP3A4TDP1GFER | |
| SCHEMBL15391387 | 0.90 | MAOB (0.62) | MAPTALDH1A1CYP3A4TDP1GFER | |
| Hydrochloric Acid SCHEMBL16699788 | 0.88 | MAOB (0.64) | MAPTALDH1A1CYP3A4TDP1GFER | |
| SCHEMBL16706883 | 0.88 | ACHE (0.59) | MAPTALDH1A1CYP3A4TDP1GFER | |
| SCHEMBL1813157 | 0.85 | HRH3 (0.67) | MAPTALDH1A1CYP3A4TDP1GFER | |
| SCHEMBL1956276 | 0.85 | MAPT (0.64) | MAPTALDH1A1CYP3A4TDP1GFER | |
| SCHEMBL9125321 | 0.83 | MAPT (0.62) | MAPTALDH1A1CYP3A4TDP1GFER | |
| Hydrochloric Acid SCHEMBL4461628 | 0.83 | HRH3 (0.64) | MAPTALDH1A1CYP3A4TDP1GFER | |
| SCHEMBL3152392 | 0.81 | MAPT (0.60) | MAPTALDH1A1CYP3A4TDP1GFER | |
| SCHEMBL1206593 | 0.81 | MAPT (0.78) | MAPTALDH1A1CYP3A4TDP1GFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092157-A1 | MACROPOROUS-STRUCTURED POLYMER AEROGELS | BLUESHIFT MAT INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-12516172-B2 | Macroporous-structured polymer aerogels | Blueshift Materials, Inc. (US) | 2026-01-06 | — | — | US | disclosed |
| EP-4655158-A2 | FLAME AND THERMAL BARRIER MATERIALS | Blueshift Materials, Inc. (US) | 2025-12-03 | — | — | EP | disclosed |
| US-20250353984-A1 | HIGHLY BRANCHED NON-CROSSLINKED AEROGEL, METHODS OF MAKING, AND USES THEREOF | BLUESHIFT MAT INC (US) | 2025-11-20 | — | — | US | disclosed |
| US-20250346018-A1 | LOW-DIELECTRIC CONSTANT, LOW-DISSIPATION FACTOR LAMINATES INCLUDING AEROGEL LAYERS | BLUESHIFT MAT INC (US) | 2025-11-13 | — | — | US | disclosed |
| US-12448492-B2 | Organic polymer aerogels comprising microstructures | Blueshift Materials, Inc. (US) | 2025-10-21 | — | — | US | disclosed |
| US-12404382-B2 | Highly branched non-crosslinked aerogel, methods of making, and uses thereof | Blueshift Materials, Inc. (US) | 2025-09-02 | — | — | US | disclosed |
| US-12391024-B2 | Low-dielectric constant, low-dissipation factor laminates including aerogel layers | Blueshift Materials, Inc. (US) | 2025-08-19 | — | — | US | disclosed |
| US-20250197583-A1 | THERMALLY TREATED POLYAMIC AMIDE AEROGEL | Blueshift Materials, Inc. (US) | 2025-06-19 | — | — | US | disclosed |
| US-20250162282-A1 | FLAME AND THERMAL BARRIER MATERIALS | Blueshift Materials, Inc. (US) | 2025-05-22 | — | — | US | disclosed |
| US-20170121483-A1 | HIGHLY BRANCHED NON-CROSSLINKED AEROGEL, METHODS OF MAKING, AND USES THEREOF | Blueshift Materials, Inc. | 2017-05-04 | — | — | US | disclosed |
| WO-2017074751-A1 | HIGHLY BRANCHED NON-CROSSLINKED AEROGEL, METHODS OF MAKING, AND USES THEREOF | BLUESHIFT INTERNATIONAL MATERIALS, INC. (US) | 2017-05-04 | — | — | WO | disclosed |
| US-9585880-B2 | Cyclic amino compounds for use in the treatment of cardiac disorders | UNIVERSITETET I OSLO (NO) | 2017-03-07 | — | — | US | disclosed |
| US-9556111-B2 | Tertiary amines for use in the treatment of cardiac disorders | UNIVERSITETET I OSLO (NO) | 2017-01-31 | — | — | US | disclosed |
| US-9556111-B2 | Tertiary amines for use in the treatment of cardiac disorders | UNIVERSITETET I OSLO (NO) | 2017-01-31 | — | — | US | disclosed |
| US-9556111-B2 | Tertiary amines for use in the treatment of cardiac disorders | UNIVERSITETET I OSLO (NO) | 2017-01-31 | — | — | US | disclosed |
| US-20150141456-A1 | CYCLIC AMINO COMPOUNDS FOR USE IN THE TREATMENT OF CARDIAC DISORDERS | UNIVERSITETET I OSLO (NO) | 2015-05-21 | — | — | US | disclosed |
| US-20150133510-A1 | TERTIARY AMINES FOR USE IN THE TREATMENT OF CARDIAC DISORDERS | UNIVERSITETET I OSLO (NO) | 2015-05-14 | — | — | US | disclosed |
| US-20150133510-A1 | TERTIARY AMINES FOR USE IN THE TREATMENT OF CARDIAC DISORDERS | UNIVERSITETET I OSLO (NO) | 2015-05-14 | — | — | US | disclosed |
| US-20150133510-A1 | TERTIARY AMINES FOR USE IN THE TREATMENT OF CARDIAC DISORDERS | UNIVERSITETET I OSLO (NO) | 2015-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092157-A1 | MACROPOROUS-STRUCTURED POLYMER AEROGELS | ACR, AQP4, AQP3 | MAPT 132/4885ALDH1A1 3320/4885CYP3A4 1739/4885 |
| US-20150133510-A1 | TERTIARY AMINES FOR USE IN THE TREATMENT OF CARDIAC DISORDERS | TNNI3, TNNT2, MYLK2 | MAPT 1886/4885ALDH1A1 1191/4885CYP3A4 4312/4885 |
| US-20150141456-A1 | CYCLIC AMINO COMPOUNDS FOR USE IN THE TREATMENT OF CARDIAC DISORDERS | TNNI3, TNNT2, AKAP8L | MAPT 2915/4885ALDH1A1 2654/4885CYP3A4 4621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.